SMAD3 and breast cancer: Consistently, GSE19536 dataset indicated that miR-135-5p was decreased in BC tissues (P < 0.001; Fig. 1E); TCGA dataset (205398_s_at) verified that the mRNA levels of SMAD3 was increased in BC samples (P < 0.001; Fig. 1F).